Cancer, Cancer Treatments, Biotechnology, Treatment, Science.
immunotherapy”. First, the team analyzed the TCR repertoire of B16F10 and Lewis lung carcinoma (LLC) tumor bearing mice, treated with the ICIs — anti-PD-L1 anti-CD4, and a combination of both (CD4 + PDL1) antibodies. They observed that the antibodies increased the mobilization of overlapping (OL)